ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 62 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $44,467,000 | -39.3% | 33,305,000 | -51.9% | 0.04% | -45.0% |
| Q4 2018 | $73,300,000 | -15.1% | 69,305,000 | -15.0% | 0.08% | +2.6% |
| Q3 2018 | $86,330,000 | -2.4% | 81,540,000 | -9.5% | 0.08% | -9.3% |
| Q2 2018 | $88,414,000 | +61.6% | 90,050,000 | +65.1% | 0.09% | +65.4% |
| Q1 2018 | $54,716,000 | -14.8% | 54,550,000 | -9.9% | 0.05% | +2.0% |
| Q4 2017 | $64,231,000 | +3.0% | 60,525,000 | +3.0% | 0.05% | -5.6% |
| Q3 2017 | $62,385,000 | +25.5% | 58,745,000 | +25.9% | 0.05% | +12.5% |
| Q2 2017 | $49,704,000 | -17.3% | 46,645,000 | -25.1% | 0.05% | -18.6% |
| Q1 2017 | $60,093,000 | -22.7% | 62,245,000 | -17.5% | 0.06% | -15.7% |
| Q4 2016 | $77,696,000 | +21.8% | 75,450,000 | +10.2% | 0.07% | +12.9% |
| Q3 2016 | $63,810,000 | – | 68,450,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |